zacks.com · 24 jun

Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know

In the most recent trading session, Pfizer (PFE) closed at $24.04, indicating a -2.75% shift from the previous trading day.

businesswire.com · 24 jun

Pfizer Declares Third-Quarter 2026 Dividend

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2026 dividend on the company's common stock, payable September 1, 2026, to holders of the Common Stock of record at the close of business on July 24, 2026. Pfizer is committed to maintaining, and over the longer term, growing the dividend, as part of its capital allocation strategy. The third-quarter 2026 cash dividend will be the 351st consecutive quarterly dividend pai.

gurufocus.com · 24 jun

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCEÂ (palbociclib) in combination with trastuzumab, with or w

businesswire.com · 24 jun

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCE® (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) locally advanced or metastatic breast cancer (MBC) following induction treatment. The approval is based on positive results from.

proactiveinvestors.com · 24 jun

Nike names former Pfizer CFO David Denton as finance chief

Nike Inc (NYSE:NKE, XETRA:NKE) has announced that David Denton will join the company as executive vice president and chief financial officer effective August 17, succeeding Matthew Friend, who will remain with the company through September 4 to support the transition. According to the company, Denton will lead Nike's global finance organization and work alongside president and CEO Elliott Hill and the senior leadership team on capital allocation, financial discipline and long-term growth initiatives.

reuters.com · 24 jun

Pfizer dismissed from US states' drug price-fixing lawsuit

Pfizer has been dismissed as a defendant in ​a sweeping antitrust lawsuit in which most U.S. states accused dozens of drugmakers ‌and executives of fixing generic drug prices.

zacks.com · 24 jun

LLY or PFE: Which Drugmaker Offers the Stronger Growth Story?

Lilly's GLP-1 leadership, expanding pipeline and strong earnings growth outlook make it a standout pick over Pfizer despite its premium valuation.

benzinga.com · 24 jun

Pfizer Stock Trades Flat Following Mixed Phase 3 Lung Cancer Trial Data

Pfizer Inc. (NYSE:PFE) shares are trading flat during Wednesday's premarket session as traders weigh mixed Phase 3 trial headlines alongside a firmer overnight tape. Here's what investors need to know.